Skip to main content

Inflammatory Bowel Disease QUOTIENT

Status: Open to Enrollment
Email us to enroll

Study details

View study details on www.clinicaltrials.gov.

Locations

  • Sunnyvale
  • Palo Alto

Clinical trial FAQs

Information for patients and study volunteers, including frequently asked questions.

This is a pragmatic, open-label, multicenter randomized control trial (RCT) conducted in asymptomatic patients with IBD who have persistent moderate to severe endoscopic inflammation despite optimization of index TIM. This study plans to recruit approximately 250 participants in the United States, who will either switching to treatment with alternative TIM to treat to a target of endoscopic remission or continue index optimized TIM. After randomization, patients will be followed prospectively within routine clinical practice over 2 years (104 weeks).

Ryan A McConnell, M.D.
Ryan A McConnell, M.D.
Principal investigator
View profile

Funder

University of California, San Diego

Related clinical trials

View all clinical trials
  • Clinical trial

    Ulcerative Colitis XmAb942-01

    A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study in Healthy Participants Followed by a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study in Participants With Moderate-To-Severe Active Ulcerative Colitis. XmAb942-01

    Status: Open to Enrollment

  • Clinical trial

    Inflammatory Bowel Disease BOOM-IBD2

    BOOM-IBD2 Clinical Trial to Evaluate the Effectiveness of Sacral Neuromodulation for the Treatment of Inflammatory Bowel Disease (IBD).

    Status: Open to Enrollment

  • Clinical trial

    Stress Urinary Incontinence PAS001 ProACT

    Post Approval Study of the ProACT™ Adjustable Continence Therapy for Men

    Status: Open to Enrollment

  • Clinical trial

    Chronic Nausea and Vomiting NAVIGATE

    A Prospective Randomized Controlled Trial of Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System

    Status: Open to Enrollment

  • Clinical trial

    Gastroparesis EXPEDITE

    Examination of Programming with the Enterra® Therapy System (EXPEDITE) in a Double-Blinded, Randomized, Prospective Study in the Treatment of Nausea and Vomiting Symptoms Using Gastric Electrical Stimulation

    Status: Open to Enrollment

You're leaving our site

The website you have selected is an external one located on another server. This website may contain links to third party sites. These links are provided for convenience purposes and are not under the control of Sutter Health. Do you wish to continue?